Function: restrictions in daily activities (4‐item Likert scale) · Morton's neuroma
The review found no eligible studies for this question.
1 finding from 1 review
Intrauterine growth restriction · pregnant women
Respiratory syncytial virus vaccine showed no clear difference in intrauterine growth restriction compared with placebo (moderate certainty).
1 finding from 1 review
Remineralization / reduction in lesion severity (change in QLF, laser fluorescence, or lesion area) · People or specimens with white spot lesions or early caries lesions
The NMA estimated an SMD of -0.78 for P11-4 + fluoride varnish versus CPP-ACP (95% CI -1.33 to -0.28).
1 finding from 1 review
SMD -0.78 [-1.33, -0.24]
Studies not reported
GRADE not reported
Mental state: psychiatric symptoms measured using the Brief Symptom Inventory (BSI) (Analysis 1.27) · outwardly aggressive behaviour in people with intellectual disability
1 finding from 1 review
Severe intraventricular haemorrhage · neonates with sepsis
It is very uncertain whether pentoxifylline with antibiotics (any dose or duration) changes severe intraventricular haemorrhage compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Periventricular leukomalacia · neonates with sepsis
It is very uncertain whether pentoxifylline with antibiotics (any dose or duration) changes periventricular leukomalacia compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Severe (grade 3 or greater) intraventricular hemorrhage (IVH) on cranial ultrasound ‐ not reported · )
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in severe intraventricular hemorrhage (grade III/IV) compared with nasal continuous positive airway pressure (NCPAP) (by population) (low certainty).
1 finding from 1 review
Neuropsychiatric SAEs · people who smoke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neuropsychiatric SAEs · people who smoke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neuropsychiatric SAEs · people who smoke
Varenicline showed no clear difference in neuropsychiatric SAEs compared with bupropion (low certainty).
1 finding from 1 review
Neuropsychiatric SAEs · people who smoke
1 finding from 1 review
Neuropsychiatric SAEs · people who smoke
Varenicline showed no clear difference in neuropsychiatric SAEs compared with combination nicotine replacement therapy (low certainty).
1 finding from 1 review
Neuropsychiatric SAEs · people who smoke
Varenicline showed no clear difference in neuropsychiatric SAEs (varenicline vs placebo or no medication) compared with placebo or no medication (low certainty).
1 finding from 1 review
Neuropsychiatric SAEs · people who continued to smoke tobacco following acute coronary syndrome
1 finding from 1 review
Neuropsychiatric SAEs · people who smoke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Faricimab · people with diabetic macular oedema
1 finding from 1 review
Intervention not reported
Faricimab · people with diabetic macular oedema
1 finding from 1 review
Intervention not reported
Faricimab (PTI) · people with diabetic macular oedema
1 finding from 1 review
Intervention not reported
Adverse events: bronchoconstriction · children and adults with cystic fibrosis
1 finding from 1 review
Quality of life on a 0 to 100 scale. Various quality of life scales. (higher score is better) · participants with idiopathic macular hole
1 finding from 1 review